Matthew Cole

Matthew Cole is a senior communications adviser with more than 15 years’ experience in both in-house and advisory roles within healthcare and life sciences. He has specialist expertise in financial and corporate communications, investor relations, media and analyst relations, fundraising, M&A, issues management, internal communications and ESG for public and private companies of all sizes.

Prior to joining Consilium, Matthew was Communications Director for Arix Bioscience plc, a London-listed biotech venture capital company. Prior to that, he spent more than a decade as a senior communications and IR adviser at FTI Consulting for clients such as Smith & Nephew, Shire, Novartis, Hikma, UCB, Bupa, PureTech Health and numerous others.